Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
Although several viruses can easily infect the central nervous system (CNS), antiviral drugs often show dramatic difficulties in penetrating the brain from the bloodstream since they are substrates of active efflux transporters (AETs). These transporters, located in the physiological barriers betwee...
Saved in:
Main Authors: | Alessandro Dalpiaz (Author), Barbara Pavan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
by: Alessandro Giuliani, et al.
Published: (2018) -
Nanoemulsions for "Nose-to-Brain" Drug Delivery
by: Maria Cristina Bonferoni, et al.
Published: (2019) -
Microemulsion-Based Media in Nose-to-Brain Drug Delivery
by: Anna Froelich, et al.
Published: (2021) -
Nose to brain delivery of drugs for CNS diseases
by: Zahraa Ali, et al.
Published: (2021) -
Nose-to-Brain Delivery
by: Paolo Giunchedi, et al.
Published: (2020)